RPN2 and neoplasm: While the knockdown of RPN2 not only inhibited the proliferation and migration of LSCC cells in vitro but also suppressed tumor growth and the expression of Ki-67, a tumor proliferation marker that was associated with tumoral aggressiveness and poor prognosis in LSCC patients [26], in a xenograft tumor model.